Protembis GmbH
PrivateLast Round
Debt
Jul 30, 2024
Total Funding Raised
$64.22M
Company Overview
Protembis GmbH operates in Healthcare & Life Sciences and is based in Aachen. Its latest recorded funding round was a Debt round in July 2024.
Protembis GmbH is a medical device company that develops the ProtEmbo® Cerebral Protection System, an intra-aortic filter device designed to protect the brain from embolic material during transcatheter aortic valve replacement (TAVR) procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Protembis GmbH Comparables
Compare Protembis GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Emboline | 94% | |
| Transverse Medical | 93% | |
| AorticLab S.r.l. | 93% |
For institutional investors. Book with your work email.
Protembis GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 30, 2024 | ||||
| Series B | Mar 26, 2024 | ||||
| Series A | Oct 26, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Protembis GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XGEN Venture | Series B |
| Tech Vision Fonds | Series B |
| European Investment Bank Group | Debt |
| Segulah Medical Acceleration | Series B |
| Coparion | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2024
$22M round led by European Investment Bank Group
- Mar 26, 2024
$33M round led by Segulah Medical Acceleration.
For institutional investors. Book with your work email.
Protembis GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Protembis GmbH's valuation, stock price, and market status.
Is Protembis GmbH a public or private company?
Protembis GmbH is a private company.
What is the current stock price of Protembis GmbH?
Protembis GmbH is a private company, so its shares have no public market price. Caplight tracks Protembis GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Protembis GmbH worth (valuation)?
Valuation information for Protembis GmbH is not publicly available.
Can I buy Protembis GmbH stock?
Protembis GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Protembis GmbH's last funding round?
Protembis GmbH's most recent funding round was Debt on July 30, 2024.
Who are the main investors in Protembis GmbH?
Key investors in Protembis GmbH include XGEN Venture, Tech Vision Fonds, European Investment Bank Group, Segulah Medical Acceleration.
Will Protembis GmbH IPO soon?
No public IPO plans have been announced for Protembis GmbH.
How can I track Protembis GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Protembis GmbH's shares on secondary markets.